New psychoactive substances

Draft Regulation amending Regulation No 73 of the Minister for Social Affairs of 18 May 2005 on conditions and procedures for handling narcotic drugs and psychotropic substances for medical and research purposes, and conditions and procedures for keeping records and reporting in that area and schedules of narcotic drugs and psychotropic substances

The purpose of the amendment is to reduce the distribution and abuse of new psychoactive substances by adding eight new substances to Schedule I of narcotic drugs and psychotropic substances in Annex 1 to Regulation No 73 of the Minister for Social Affairs of 18 May 2005:

1) Meclonazepam; (S)-3-methylclonazepam;(3S)-5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one

2) Nifoxipam; 5-(2-fluorophenyl)-3-hydroxy-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one, 3-hydroxydesmethylflunitrazepam

3) Ephenidine; N-ethyl-1,2-diphenylethylamine (NEDPA; EPE)

4) 1-naphthalenyl(1-pentyl-1H-indazol-3-yl)-methanone; THJ-018

5) 4-fluoroethylphenidate; p-fluoroethylphenidate; ethyl-(4-fluorophenyl)(piperidin-2-yl)acetate (4F-EPH)

6) Metizolam; desmethyletizolam; 4-(2-chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine

7) 1-propionyl-lysergic acid diethylamide;
N,N-diethyl-7-methyl-4-propanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
(1P-LSD; 1p-LSD)

8) Dimethylamylamine; 1,3-dimethylamylamine; methylhexanamine, 4-methyl-2-hexanamine (DMAA; 1,3-DMAA)